- CODEN : IAJPBB
- issn 2349-7750
TITLE:
A RANDOMIZED CONTROLLED TRIAL TO DETERMINE THE EFFICACY OF 0.9% SALINE VS HYPERTONIC (3%) SALINE FOR ACUTE VIRAL BRONCHIOLITIS
AUTHORS:
Dr Ahmad Zaki, Dr Zainab Riaz, Sonia Rehman Orakzai
ABSTRACT:
Aim: To compare the length of hospital stay (primary) and improvement of clinical (secondary) severity indices in children with bronchiolitis nebulized with 3% hypertonic saline or 0.9% saline. Design: Randomized double-blind controlled trial. Place and Duration: In the Pediatric department of Khyber Teaching Hospital Peshawar for six-months duration from January 2020 to July 2020. Methods: Hospitalized children (1-24 months) with moderate acute bronchiolitis were included. Nebulize 4 ml of 3% hypertonic saline or 4 ml of 0.9% saline with 2.5 mg of salbutamol at 4-hour intervals until the patient is ready for discharge. Results: Baseline characteristics were similar in the two groups. The median clinical grade on admission was 6 (IQR-1) in both groups. Clinical severity markers monitored 12 hours to discharge (132 hours) showed no statistically significant differences in the 3% and 0.9% salt groups. The mean hospital stay (time to the predefined clinical severity score <3) was 63.93 ± 22.43 h in the 3% saline group and 63.51 ± 21.27 h in the 0.9% saline group (P = 0.878). In both groups, no adverse events were reported by parents, or healthcare professionals. Conclusion: Nebulized 3% saline does not exceed 0.9% saline in infants with clinically diagnosed acute bronchiolitis. Key words: nebulization with 3% saline, bronchiolitis, management
FULL TEXT
<Approved Journal
NLM ID:101711216 [Serial]
Included in EuroPub database
ICV 2015 - 61.16
Indexed In
S.J Impact Factor:7.157
cosmos Impact Factor:4.153
ICMJE Recommendations
IP Indexing Impact Factor: 2.76
Cover Page
